Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Pharm Res. 2010 Apr 13;28(1):135–144. doi: 10.1007/s11095-010-0134-6

Fig. 5.

Fig. 5

Immunogenicity of influenza vaccine coated onto microneedles after drying and storage. Influenza virus-specific antibody response at 1, 2, and 4 weeks after immunization with coated microneedles formulated with (+) or without (−) 15% trehalose after storage for up to 1 month at 25°C. (A) Total influenza virus-specific serum IgG, (B) subtype IgG1, (C) subtype IgG2a, (D) subtype IgG2b and (E) IgG1/IgG2a ratio. (n=6 replicates expressed as average ± SEM).